337 related articles for article (PubMed ID: 21163196)
1. Effectiveness and safety of the schedules of short and long term treatment for tuberculous meningoencephalitis at two hospitals of Lima--Peru.
Morales S; Ramos W; Vílchez R; Pérez J; Alvarado M
Neurologia; 2011 May; 26(4):220-6. PubMed ID: 21163196
[TBL] [Abstract][Full Text] [Related]
2. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
Zierski M; Bek E
Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
[No Abstract] [Full Text] [Related]
3. Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis.
Tabarsi P; Baghaei P; Hemmati N; Mirsaeidi M; Kazempour M; Mansouri D; Masjedi MR
East Mediterr Health J; 2009; 15(6):1346-50. PubMed ID: 20218123
[TBL] [Abstract][Full Text] [Related]
4. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].
Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R
Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281
[TBL] [Abstract][Full Text] [Related]
5. Side-effects of drugs used in directly observed treatment short-course in newly diagnosed pulmonary tuberculosis subjects in Nigerians: a controlled clinical study.
Dosumu EA
Niger Postgrad Med J; 2002 Mar; 9(1):34-7. PubMed ID: 11932759
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug reactions observed during DOTS.
Dhingra VK; Rajpal S; Aggarwal N; Aggarwaln JK; Shadab K; Jain SK
J Commun Dis; 2004 Dec; 36(4):251-9. PubMed ID: 16506547
[TBL] [Abstract][Full Text] [Related]
7. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
8. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
Gordin F; Chaisson RE; Matts JP; Miller C; de Lourdes Garcia M; Hafner R; Valdespino JL; Coberly J; Schechter M; Klukowicz AJ; Barry MA; O'Brien RJ
JAMA; 2000 Mar; 283(11):1445-50. PubMed ID: 10732934
[TBL] [Abstract][Full Text] [Related]
9. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
[TBL] [Abstract][Full Text] [Related]
10. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
[TBL] [Abstract][Full Text] [Related]
11. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of tuberculosis in the adult].
Schrappe M; Wassermann K; Kroegel C
Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
[No Abstract] [Full Text] [Related]
13. Treatment of tuberculous meningitis: role of short-course chemotherapy.
Phuapradit P; Vejjajiva A
Q J Med; 1987 Mar; 62(239):249-58. PubMed ID: 3659258
[TBL] [Abstract][Full Text] [Related]
14. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
[TBL] [Abstract][Full Text] [Related]
15. Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
Reves R; Heilig CM; Tapy JM; Bozeman L; Kyle RP; Hamilton CD; Bock N; Narita M; Wing D; Hershfield E; Goldberg SV;
Int J Tuberc Lung Dis; 2014 May; 18(5):571-80. PubMed ID: 24903795
[TBL] [Abstract][Full Text] [Related]
16. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
[TBL] [Abstract][Full Text] [Related]
17. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
[TBL] [Abstract][Full Text] [Related]
18. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade.
Snider DE; Zierski M; Graczyk J; Bek E; Farer LS
Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281
[TBL] [Abstract][Full Text] [Related]
19. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
[TBL] [Abstract][Full Text] [Related]
20. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
Small PM; Schecter GF; Goodman PC; Sande MA; Chaisson RE; Hopewell PC
N Engl J Med; 1991 Jan; 324(5):289-94. PubMed ID: 1898769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
